Subclinical thyroid dysfunction and cardiovascular outcomes among prospective cohort studies

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 13, Issue 1, 2013, Pages 4-12

  Gencer, Baris ^a,b   Collet, Tinh Hai ^b   Virgini, Vanessa ^c   Auer, Reto ^b,d   Rodondi, Nicolas ^c  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiovascular epidemiology; Coronary heart disease; Heart failure; Meta analysis; Subclinical thyroid dysfunction

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE;

CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; EUTHYROIDISM; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SUBCLINICAL HYPERTHYROIDISM; SUBCLINICAL HYPOTHYROIDISM; THYROID DISEASE;

ASYMPTOMATIC DISEASES; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; COHORT STUDIES; HUMANS; PROGNOSIS; THYROID DISEASES;

EID: 84875845880     PISSN: 18715303     EISSN: 22123873     Source Type: Journal    
DOI: 10.2174/1871530311313010003     Document Type: Review

References (56)

1. Gersh, B. J.; Sliwa, K.; Mayosi, B. M. and Yusuf, S. (2010) Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. Eur. Heart J., 31(6), 642-648.
2. Yusuf, S.; Reddy, S.; Ounpuu, S. and Anand, S. (2001) Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation, 104, 2746-2753.
3. Curtis, L. H.; Whellan, D. J.; Hammill, B. G.; Hernandez, A. F.; Anstrom, K. J.; Shea, A. M. and Schulman, K. A. (2008) Incidence and prevalence of heart failure in elderly persons, 1994-2003. Arch. Intern. Med., 168, 418-424.
4. Roger V. L.; Weston, S. A.; Redfield, M. M.; Hellermann-Homan, J. P.; Killian, J.; Yawn, B. P. and Jacobsen, S. J. (2004) Trends in heart failure incidence and survival in a community-based population. JAMA, 292, 344-350.
5. Butler, J.; Kalogeropoulos, A.; Georgiopoulou, V.; Belue, R.; Rodondi, N.; Garcia, M.; Bauer, D. C.; Satterfield, S.; Smith, A. L.; Vaccarino, V.; Newman, A. B.; Harris, T. B.; Wilson, P. W.; Kritchevsky, S. B. and Health, ABC Study. (2008) Incident heart failure prediction in the elderly: the health ABC heart failure score. Circul. Heart Fail., 1, 125-133.
6. Hollowell, J. G.; Staehling, N. W.; Flanders, W. D.; Hannon, W. H.; Gunter, E. W.; Spencer, C. A. and Braverman, L. E. (2002) Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). Clin. Endocrinol. Metab., 87, 489-499.
7. Biondi, B.; Palmieri, E. A.; Lombardi, G.; Fazio, S. (2002) Effects of subclinical thyroid dysfunction on the heart. Ann. Intern. Med., 137, 904-914.
8. Surks, M. I.; Ortiz, E.; Daniels, G. H.; Sawin, C. T.; Col, N. F.; Cobin, R. H.; Franklyn, J. A.; Hershman, J. M.; Burman, K. D.; Denke, M. A.; Gorman, C.; Cooper, R. S. and Weissman, N. J. (2004) Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA, 291, 228-238.
9. Helfand, M. (2004) Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann. Intern. Med., 140, 128-41.
10. Bahn, R. S.; Burch, H. B.; Cooper, D. S.; Garber, J. R.; Greenlee, M. C.; Klein, I.; Laurberg, P.; McDougall, I. R.; Montori, V. M.; Rivkees, S. A.; Ross, D. S.; Sosa, J. A. and Stan, M. N.; American Thyroid, A. and American Association of Clinical, E., Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr. Pract., 17, 456-520.
11. Gharib, H.; Tuttle, R. M.; Baskin, H. J.; Fish, L. H.; Singer, P. A. and McDermott, M. T. (2005) Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J. Clin. Endocrinol. Metab., 90, 581-585.
12. Cooper, D. S. and Biondi, B. (2012) Subclinical thyroid disease. Lancet, 379, 1142-1154.
13. Ochs, N.; Auer, R.; Bauer, D. C.; Nanchen, D.; Gussekloo, J.; Cornuz, J. and Rodondi, N. (2008) Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann. Intern. Med., 148, 832-845.
14. Razvi, S.; Shakoor, A.; Vanderpump, M.; Weaver, J. U. and Pearce, S. H. (2008) The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J. Clin. Endocrinol. Metab., 93, 2998-3007.
15. Volzke, H.; Schwahn, C.; Wallaschofski, H. and Dorr, M. (2007) The association of thyroid dysfunction with all-cause and circulatory mortality: is there a causal relationship? J. Clin. Endocrinol. Metab., 92, 2421-2429.
16. Ladenson, P. W. (2008) Cardiovascular consequences of subclinical thyroid dysfunction: more smoke but no fire. Ann. Intern. Med., 148, 880-881.
17. Rodondi, N.; den Elzen, W. P.; Bauer, D. C.; Cappola, A. R.; Razvi, S.; Walsh, J. P.; Asvold, B. O.; Iervasi, G.; Imaizumi, M.; Collet, T. H.; Bremner, A.; Maisonneuve, P.; Sgarbi, J. A.; Khaw, K. T.; Vanderpump, M. P.; Newman, A. B.; Cornuz, J.; Franklyn, J. A.; Westendorp, R. G.; Vittinghoff, E.; Gussekloo, J. and Thyroid Studies, C. (2010) Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA, 304, 1365-1374.
18. Collet, T. H.; Gussekloo, J.; Bauer, D. C.; den Elzen, W. P.; Cappola, A. R.; Balmer, P.; Iervasi, G.; Asvold, B. O.; Sgarbi, J. A.; Volzke, H.; Gencer, B.; Maciel, R. M.; Molinaro, S.; Bremner, A.; Luben, R. N.; Maisonneuve, P.; Cornuz, J.; Newman, A. B.; Khaw, K. T.; Westendorp, R. G.; Franklyn, J. A.; Vittinghoff, E.; Walsh, J. P.; Rodondi, N. and Thyroid Studies, C. (2012) Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch. Intern. Med., 172, 799-809.
19. Gencer, B.; Collet, T. H.; Virgini, V.; Bauer, D. C.; Gussekloo, J.; Cappola, A. R.; Nanchen, D.; den Elzen, W. P.; Balmer, P.; Luben, R. N.; Iacoviello, M.; Triggiani, V.; Cornuz, J.; Newman, A. B.; Khaw, K. T.; Jukema, J. W.; Westendorp, R. G.; Vittinghoff, E.; Aujesky, D.; Rodondi, N. and Thyroid Studies, C. (2012) Subclinical Thyroid Dysfunction and the Risk of Heart Failure Events: An Individual Participant Data Analysis From 6 Prospective Cohorts. Circulation, 126, 1040-1049.
20. Biondi, B. (2012) Heart failure and thyroid dysfunction. Eur. J. Endocrinol., 167, 609-618.
21. Biondi, B. and Cooper, D. S. (2008) The clinical significance of subclinical thyroid dysfunction. Endocr. Rev., 29, 76-131.
22. Klein, I. and Ojamaa, K. (2001) Thyroid hormone and the cardiovascular system. N. Engl. J. Med., 344, 501-509.
23. Klein, I. and Danzi, S. (2007) Thyroid disease and the heart. Circulation, 116, 1725-1735.
24. Riley, R. D.; Lambert, P. C. and Abo-Zaid, G. (2010) Metaanalysis of individual participant data: rationale, conduct, and reporting. BMJ, 340, c221.
25. Riley, R. D.; Simmonds, M. C. and Look, M. P. (2007) Evidence synthesis combining individual patient data and aggregate data: a systematic review identified current practice and possible methods. J. Clin. Epidemiol., 60, 431-439.
26. Simmonds, M. C.; Higgins, J. P.; Stewart, L. A.; Tierney, J. F.; Clarke, M. J. and Thompson, S. G. (2005) Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clin. Trials, 2, 209-217.
27. Cappola, A. R.; Fried, L. P.; Arnold, A. M.; Danese, M. D.; Kuller, L. H.; Burke, G. L.; Tracy, R. P. and Ladenson, P. W. (2006) Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295, 1033-1041.
28. Walsh, J. P.; Bremner, A. P.; Bulsara, M. K.; O'Leary, P.; Leedman, P. J.; Feddema, P. and Michelangeli, V. (2005) Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch. Intern. Med., 165, 2467-2472.
29. Boekholdt, S. M.; Titan, S. M.; Wiersinga, W. M.; Chatterjee, K.; Basart, D. C.; Luben, R.; Wareham, N. J. and Khaw, K. T. (2010) Initial thyroid status and cardiovascular risk factors: the EPICNorfolk prospective population study. Clin. Endocrinol., 72, 404-410.
30. Somwaru, L. L.; Rariy, C. M.; Arnold, A. M. and Cappola, A. R. (2012) The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study. J. Clin. Endocrinol. Metab., 97, 1962-1969.
31. Hak, A. E.; Pols, H. A.; Visser, T. J.; Drexhage, H. A.; Hofman, A. and Witteman, J. C. (2000) Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann. Intern. Med., 132, 270-278.
32. Galli, E.; Pingitore, A. and Iervasi, G. (2010) The role of thyroid hormone in the pathophysiology of heart failure: clinical evidence. Heart Fail. Rev., 15, 155-169.
33. Monzani, F.; Di Bello, V.; Caraccio, N.; Bertini, A.; Giorgi, D.; Giusti, C. and Ferrannini, E. (2001) Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study. J. Clin. Endocrinol. Metab., 86, 1110-1115.
34. Monzani, F.; Caraccio, N.; Kozakowa, M.; Dardano, A.; Vittone, F.; Virdis, A.; Taddei, S.; Palombo, C. and Ferrannini, E. (2004) Effect of levothyroxine replacement on lipid profile and intimamedia thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study. J. Clin. Endocrinol. Metab., 89, 2099-2106.
35. Razvi, S.; Ingoe, L.; Keeka, G.; Oates, C.; McMillan, C. and Weaver, J. U. (2007) The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. J. Clin. Endocrinol. Metab., 92, 1715-1723.
36. Biondi, B.; Palmieri, E. A.; Fazio, S.; Cosco, C.; Nocera, M.; Sacca, L.; Filetti, S.; Lombardi, G. and Perticone, F. (2000) Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J. Clin. Endocrinol. Metab., 85, 4701-4705.
37. Biondi, B. (2012) How could we improve the increased cardiovascular mortality in patients with overt and subclinical hyperthyroidism? Eur. J. Endocrinol., 167, 295-299.
38. Haentjens, P.; Van Meerhaeghe, A.; Poppe, K. and Velkeniers, B. (2008) Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on timeto-event data from cohort studies. Eur. J. Endocrinol., 159, 329-341.
39. Sawin, C. T.; Geller, A.; Wolf, P. A.; Belanger, A. J.; Baker, E.; Bacharach, P.; Wilson, P. W.; Benjamin, E. J. and D'Agostino, R. B. (1994) Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N. Engl. J. Med., 331, 1249-1252.
40. Auer, J.; Scheibner, P.; Mische, T.; Langsteger, W.; Eber, O. and Eber, B. (2001) Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am. Heart J., 142, 838-42.
41. Gammage, M. D.; Parle, J. V.; Holder, R. L.; Roberts, L. M.; Hobbs, F. D.; Wilson, S.; Sheppard, M. C. and Franklyn, J. A. (2007) Association between serum free thyroxine concentration and atrial fibrillation. Arch. Intern. Med., 167, 928-934.
42. Fatourechi, V.; Lankarani, M.; Schryver, P. G.; Vanness, D. J.; Long, K. H. and Klee, G. G. (2003) Factors influencing clinical decisions to initiate thyroxine therapy for patients with mildly increased serum thyrotropin (5.1-10.0 mIU/L). Mayo Clin. Proc., 78, 554-560.
43. Hunt, S. A.; Abraham, W. T.; Chin, M. H.; Feldman, A. M.; Francis, G. S.; Ganiats, T. G.; Jessup, M.; Konstam, M. A.; Mancini, D. M.; Michl, K.; Oates, J. A.; Rahko, P. S.; Silver, M. A.; Stevenson, L. W. and Yancy, C. W. (2009) 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation, 119, e391-479.
44. Cappola, A. R. (2007) Subclinical thyroid dysfunction and the heart. J. Clin. Endocrinol. Metab., 92, 3404-3405.
45. Rodondi, N.; Newman, A. B.; Vittinghoff, E.; de Rekeneire, N.; Satterfield, S.; Harris, T. B. and Bauer, D. C. (2005) Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch. Inter. Med., 165, 2460-2406.
46. Parle, J. V.; Maisonneuve, P.; Sheppard, M. C.; Boyle, P. and Franklyn, J. A. (2001) Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet, 358, 861-865.
47. Boekholdt, S. M.; Titan, S. M.; Wiersinga, W. M.; Chatterjee, K.; Basart, D. C.; Luben, R.; Wareham, N. J. and Khaw, K. T. (2010) Initial thyroid status and cardiovascular risk factors: the EPICNorfolk prospective population study. Clin. Endocrinol., 72, 404-410.
48. Asvold, B. O.; Bjoro, T.; Nilsen, T. I.; Gunnell, D. and Vatten, L. J. (2008) Thyrotropin levels and risk of fatal coronary heart disease: the HUNT study. Arch Inter. Med., 168, 855-860.
49. Gussekloo, J.; van Exel, E.; de Craen, A. J.; Meinders, A. E.; Frolich, M. and Westendorp, R. G. (2004) Thyroid status, disability and cognitive function, and survival in old age. JAMA, 292, 2591-2519.
50. Iervasi, G.; Molinaro, S.; Landi, P.; Taddei, M. C.; Galli, E.; Mariani, F.; L'Abbate, A. and Pingitore, A. (2007) Association between increased mortality and mild thyroid dysfunction in cardiac patients. Arch. Intern. Med., 167, 1526-1532.
51. Vanderpump, M. P.; Tunbridge, W. M.; French, J. M.; Appleton, D.; Bates, D.; Clark, F.; Grimley Evans, J.; Rodgers, H.; Tunbridge, F. and Young, E. T. (1996) The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid, 6, 155-160.
52. Ittermann, T.; Haring, R.; Sauer, S.; Wallaschofski, H.; Dorr, M.; Nauck, M.; Volzke, H. (2010) Decreased serum TSH levels are not associated with mortality in the adult northeast German population. Eur. J. Endocrinol., 162, 579-585.
53. Nanchen, D.; Gussekloo, J.; Westendorp, R. G.; Stott, D. J.; Jukema, J. W.; Trompet, S.; Ford, I.; Welsh, P.; Sattar, N.; Macfarlane, P. W.; Mooijaart, S. P.; Rodondi, N.; de Craen, A. J. and Group, P. (2012) Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk. J. Clin. Endocrinol. Metab., 97, 852-861.
54. Iacoviello, M.; Guida, P.; Guastamacchia, E.; Triggiani, V.; Forleo, C.; Catanzaro, R.; Cicala, M.; Basile, M.; Sorrentino, S. and Favale, S. (2008) Prognostic role of sub-clinical hypothyroidism in chronic heart failure outpatients. Curr. Pharm. Des., 14, 2686-2692.
55. Sgarbi, J. A.; Matsumura, L. K.; Kasamatsu, T. S.; Ferreira, S. R. and Maciel, R. M. (2010) Subclinical thyroid dysfunctions are independent risk factors for mortality in a 7.5-year follow-up: the Japanese-Brazilian thyroid study. Eur. J. Endocrinol., 162, 569-577.
56. Imaizumi, M.; Akahoshi, M.; Ichimaru, S.; Nakashima, E.; Hida, A.; Soda, M.; Usa, T.; Ashizawa, K.; Yokoyama, N.; Maeda, R.; Nagataki, S. and Eguchi, K. (2004) Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J. Clin. Endocrinol. Metab., 89, 3365-3370.